Quarterly Report
Filed: 2026-02-13
Key Insights
- Bodhi Tree Biotechnology Inc. reported a net loss of $52,948 for the quarter ended December 31, 2025, an improvement from the $64,777 loss in the same period of the prior year.
- The company's cash balance declined to $47,366 as of December 31, 2025, down from $109,404 at the end of the prior quarter, indicating potential liquidity concerns.
- Bodhi Tree Biotechnology did not generate any revenue during the quarter, a decline from the $5,000 in revenue reported in the same period of the prior year, raising questions about the company's commercial progress.